Tag:

Hib vaccine

Latest Headlines

Latest Headlines

FDA expands indication for GSK's Hib vaccine, Hiberix

In 2009, GlaxoSmithKline worked with U.S. health authorities to bring its Haemophilus influenzae Type b (Hib) vaccine, Hiberix, to market. Now, the FDA has expanded the indication of GSK's Hiberix from a booster to a full-series, four-dose vaccine to immunize children aged 6 weeks to four years.

Nuron Biotech nabs $80M from HealthCare Royalty Partners

Just days after snagging Pfizer's ($PFE) meningitis, sepsis and pneumonia vaccine, Nuron Biotech landed an $80 million deal to further elevate its expanding porfolio of vaccines.

Nuron acquires Pfizer's meningitis vaccine

Startup Nuron Biotech acquired from Pfizer a vaccine to protect against meningitis, sepsis and pneumonia for an undisclosed amount.

FDA green-lights GSK's MenHibrix

The vaccine targets infections with Neisseria meningitidis serogroups C and Y and Haemophilus influenzae type B, and is given as four doses between 6 weeks and 18 months of age. Both of these infections can cause meningitis.

Hib infections on the rise due to vax shortage

Officials are reporting that the number of children infected with Hib, or Haemophilus influenzae type b, continue to rise due to a shortage of Merck's childhood vaccine. There have been at least ten

Hib cases rise during vaccine shortage

Minnesota health officials are drawing a link between the shortage of Merck's Hib childhood vaccine and an increase in that disease, which can cause meningitis and pneumonia. They are reporting five

Hib cases rise during vaccine shortage

Minnesota health officials are drawing a link between the shortage of Merck's Hib childhood vaccine and an increase in that disease, which can cause meningitis and pneumonia. They are reporting five

SPOTLIGHT: CDC halts Hib boosters after Merck recall

In the wake of Merck's Hib vaccine recall, the CDC is telling docs to stop giving the booster shot that comes due for infants at 12 to 15 months. Sanofi Pasteur won't be able to make up the

Merck recalls Hib shots, causing shortage

We're about to use the words "impending vaccine shortage," but not about flu shots. Today, Merck recalled more than a million doses of Hib vaccine, shots given to kids under five to prevent